Sanjit S Jolly1, Madhu K Natarajan1. Show Affiliations » 1. From the Population Health Research Institute and Department of Medicine, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Abstract
Entities: Chemical Disease
Mesh： See more » Anticoagulants/therapeutic useAspirin/therapeutic useAtrial Fibrillation/drug therapyCerebrovascular Disorders/drug therapyHumansPlatelet Aggregation Inhibitors/therapeutic useRisk FactorsTiclopidine/therapeutic useWarfarin
Substances： See more » AnticoagulantsPlatelet Aggregation InhibitorsWarfarinTiclopidineAspirin
Year: 2016 PMID： 28002706 DOI： 10.1056/NEJMe1613474
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245